Navigation Links
Loma Linda University Medical Center Celebrates Groundbreaking on Inland Empire's Most Comprehensive Rehabilitation Center
Date:2/27/2008

New Rehabilitation Pavilion Offers Unique Skills Training Where Patients Replicate Real-World Challenges in Environment of Enhanced Learning and

Personal Support

LOMA LINDA, Calif., Feb. 27 /PRNewswire/ -- Loma Linda University Medical Center (LLUMC), the Inland Empire's leader in physical rehabilitation for survivors of stroke, fractures, amputations, brain injuries, neurological disorders, spinal cord injuries, joint replacements, and other disabling illnesses or injuries, has broken ground on a 30,000-square-foot, 24-bed rehabilitation pavilion that will bring unique services to the region.

The new Tom & Vi Zapara Rehabilitation Pavilion will include the imaginative "Independence Square" where patients will have the opportunity to experience many real-world situations and challenges in a safe and teaching environment. The new facility is the latest addition to the medical center's 23-acre East Campus, whose Rehabilitation, Orthopedic & Neurosciences Institute (RONI) places among the top 3 percent of such facilities in the nation, according to a survey by the Commission on Accreditation of Rehabilitation Facilities.

The February 25 groundbreaking and tree planting ceremony drew more than 200 attendees, many of whom were survivors of disabling injuries.

"The rehabilitation pavilion -- the only one of its kind in the Inland Empire -- has been uniquely designed to address the physical and psychological needs of survivors of disabling illness and injury," said Michael Jackson, administrator and senior vice president of Loma Linda University Medical Center East Campus. "The environment will offer healing spaces that are physically and psychologically supportive of patients and their families, with the goal of reducing stress and promoting a sense of well-being and health.

"Research by the Center for Health Design has shown that a hospital's physical environment and care philosophy is closely link
'/>"/>

SOURCE Loma Linda University Medical Center
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
2. Care Net Announces New Leadership: Melinda Delahoyde to Follow Kurt Entsminger as President
3. Avicena Appoints Dr. Belinda Tsao-Nivaggioli as Chairman of the Board of Directors
4. Bill and Melinda Gates Call for New Global Commitment to Chart a Course for Malaria Eradication
5. Infectious Disease Research Institute Receives Grant from the Bill & Melinda Gates Foundation for Adjuvant Access and Development
6. Loma Linda University to Dedicate Proton Treatment Center to Cancer Therapy Pioneer James M. Slater, M.D.
7. AMERIGROUP Names Linda Whitley-Taylor as Executive Vice President, Associate Services
8. Linda Ellerbee to Present Keynote at URACs Best Practices in Consumer Empowerment and Protection Awards Program
9. University of Iowa professor identifies new eating disorder
10. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
11. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , , KNOXVILLE, Tenn., Dec. 2 /PRNewswir...s presence in Southwest Florida with the acquisiti... LLC (EPN). Since January 2002, EPN has held an e...aff the emergency facilities at the Downtown Naple...ealthcare Clinic. EPN also provides the staffing f...
(Date:12/2/2009)... , Waltham, MAJoseph Balboni loves sports. An avi...n, the 46-year-old insurance agent became increasi...ue to keratoconus, a degenerative eye disorder. Un... Red Sox games, he faced the prospect of a corneal... , Then three years ago, Balboni discovered an a...
(Date:12/2/2009)... , EUROECHO 2009 is the official congress of the ...registered branch of the European Society of Cardi... imaging will be presented. , New case reports ...e latest evidence highlighting the role of this ne...t in imaging techniques, it is likely that non-inv...
(Date:12/2/2009)... , National Pen ( www.pen...retailer, announced today it is giving away 10,000... (PRWEB) December 2, 2009 -- National Pen ( www....ts retailer announced today it is giving away 10,0...ve a new way to promote business that no other com...
(Date:12/2/2009)... , Revolutionary new cell... away from users will be available in early 2010 f... (PRWEB) December 2, 2009 -- Revolutionary ...missions away from users will be available in earl...gy was recently honored with a Green Technology Aw...
Breaking Medicine News(10 mins):Health News:TeamHealth Acquires Emergency Physicians of Naples, LLC 2Health News:Brandeis studies evaluate visionary approach to improving eyesight 2Health News:Media alert: EUROECHO 2009 2Health News:National Pen Giving Away 10,000 Business Card Pens 2Health News:New AERIUS Cell Phones Direct Microwave Signals Away from Users 2
...,s revised statistics regarding new HIV infections...://www.requestatest.com/ [HIV testing __title__ H...ons infected don,t know they carry the HIV virus. ...decade. This was the surprising announcement made ...
...rma, Inc.,(Amex: DDD ) announced today that it ha... Abbreviated New Drug Application (ANDA) for a 120... the Company,s patented,Controlled Delivery Techno...ra(R) D, Sudafed(R),PSE, Claritin(R) D, Zyrtec(R) ...
...Technology Investments Streamline Processes, Acc...dy, NASHVILLE, Tenn., Aug. 5 HealthLeaders-Inter...ntelligence, reports that Health,Care Service Corp...lue Profiler: Health Care Service Corporation, the...
...,Therapeutics (Nasdaq: NKTR ) today announced the... the position of Senior Vice President of Drug,Dev...ugust 11, 2008. Dr.,Moreadith will report to Nekta...and Regulatory Affairs at Nektar. He is,responsibl...
...aceutical,Services, Inc. (NYSE: WST ) today annou...ef Financial Officer, and Michael Anderson, Vice P...vices, Inc., will be presenting at,the CJS Securit... conference will be available through the Investor...
...y-stage patients who don,t yet need dialysis, stud...ws) -- Monitoring levels of a hormone called fibro...reatment of kidney failure patients, say Massachus...s were much more likely to die within the first ye...
Other Medicine News:Health News:Why Affordable HIV Testing Is More Important Than Ever: "HIV Epidemic 40% Higher Than Estimates" 2Health News:Why Affordable HIV Testing Is More Important Than Ever: "HIV Epidemic 40% Higher Than Estimates" 3Health News:SCOLR Pharma, Inc. Submits Abbreviated New Drug Application for a 12-hour CDT-based Pseudoephedrine Formulation 2Health News:SCOLR Pharma, Inc. Submits Abbreviated New Drug Application for a 12-hour CDT-based Pseudoephedrine Formulation 3Health News:Insurance Giant Leverages Technology to Enhance Offerings 2Health News:Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer 2Health News:Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer 3Health News:Monitoring Hormone May Improve Kidney Failure Outcomes 2
(Date:12/2/2009)... HAIFA, Isreal, December 2 /PRNewswire-FirstCall/..., a leading developer of advanced,cardiovascular s...y,s Board,of Directors approved a one-for-three fo..., payable to Cardio Vascular Medical Device shareh...e course the estimated date the stock,split will b...
(Date:12/2/2009)...VILLAGE, Nev., Dec. 2 PD...ounced that it has established the per share amoun... dividend as $1.67 per share. The dividend will be...ompany,s stock as of the December 1, 2009 record d...te per share amount of the dividend at $1.67 per s...
(Date:12/2/2009)...TON, Calif., Dec. 2 Roch...t the United States Food & Drug Administration... licensed nucleic acid test, to screen source plas...ions. The test, called the cobas® TaqScreen M...qualitative, in-vitro test for the simultaneous, d...
Breaking Medicine Technology:Cardio Vascular Medical Device Announces Forward Stock Split 2PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 2PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 3FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 3Hospital Group Receives 241 Million Grant to Help Patients Access Health Insurance 58697 1Hospital Group Receives 241 Million Grant to Help Patients Access Health Insurance 58697 24 000 Registered for Redlands 2nd Annual Believe and Walk for the Cure 58695 14 000 Registered for Redlands 2nd Annual Believe and Walk for the Cure 58695 24 000 Registered for Redlands 2nd Annual Believe and Walk for the Cure 58695 3Thousands of Dental Professionals Arrive in Honolulu for ADAs 150th Annual Session 58693 1Thousands of Dental Professionals Arrive in Honolulu for ADAs 150th Annual Session 58693 2
...2007 - Researchers at,the Stanford University Scho...om their new study indicating that an antidepressa...behavioral disorder,known as compulsive buying, di...ts who took it., The medication is escitalopram, a... brand name Lexapro. In the study,researchers fou...
...ng for C1-inhibitor,replacement therapy, NEW YORK,...maceuticals, Inc. (Lev) today announced positive r...-esterase inhibitor (C1-INH),for the acute treatme...udy, which is part of the company,s CHANGE trials,...ion Generation,evaluating Efficacy), the protocol-...
Other Medicine Technology:Study of Drug Therapy for Compulsive Buying Yields a Puzzle,Stanford Researcher Says 2Study of Drug Therapy for Compulsive Buying Yields a Puzzle,Stanford Researcher Says 3Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 2Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 3Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 4Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III,Trial for Hereditary Angioedema 5
Blue Line® Intubation Stylet 7.5 mm 10 mm
Blue Line® Intubation Stylet 2.5 mm 4.5 mm
Surch-Lite™ Flexible Light - 15" Sterile
Surch-Lite™ Flexible Light - 5" Non-Sterile
Medicine Products: